通过临床监测工具增强药物过敏反应文档
概括
在电子健康记录 (EHR) 中改善药物过敏反应 (DHR) 文档对于患者安全至关重要. 一个质量改进项目成功地使用临床监测工具在急诊室 (ED) 中提高了DHR文档化率.
科学领域:
- 临床药房 临床药房
- 患者安全 患者安全
- 医疗信息学 医疗信息学
背景情况:
- 药物过敏反应 (DHRs) 是对药物的严重免疫反应.
- 在电子健康记录 (EHR) 中准确记录DHR对于患者安全至关重要.
- 在退伍军人事务急诊部 (ED) 发现了大量的DHRs (25.6%) 文件不足.
研究的目的:
- 实施质量改进 (QI) 项目,以提高 DHR 文档化率.
- 在6个月内实现DHR记录率≥50%的目标.
- 利用临床监测工具来增强DHR报告.
主要方法:
- 一个由药剂师领导的QI项目在一个VAED中进行.
- 实施了一种临床监测工具,以监测和改进DHR文档.
- 每个月使用定义的指标测量DHR文档化率.
- 统计过程控制 (SPC) 与指数加权移动平均线 (EWMA) 被用于分析.
主要成果:
- 在6个月的时间里,DRH记录率从25.6%上升到65.4%.
- 干预成功超越了50%的文档的目标目标.
- 欧洲食品药品管理协会 (EWMA) 的SPC分析表明,文档化率持续改善.
结论:
- 一个由药剂师领导的QI倡议有效地改善了ED环境中的DHR文档.
- 临床监测工具代表了一个低成本,可行的解决方案,以提高DHR报告.
- 改善了DRH的EHR文档,通过提醒医疗保健团队对药物风险来提高患者安全.
相关概念视频
Allergic Reactions
29.0K
Overview
29.0K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Pharmacovigilance
1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Allergic Drug Reactions
1.0K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.0K
Desensitization and Tachyphylaxis
2.3K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.3K
Hypersensitivities
1.1K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.1K


